Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension

Bita Hajian,1 Jan De Backer,2 Wim Vos,2 Cedric Van Holsbeke,2 Francisca Ferreira,2 Deborah A Quinn,3 Annemie Hufkens,1 Rita Claes,1 Wilfried De Backer1 1Department of Respiratory Medicine, University Hospital Antwerp, Edegem, 2FluidDA nv, Antwerp, Belgium; 3Bellerophon Therapeutics, Warren, NJ, USA...

Full description

Bibliographic Details
Main Authors: Hajian B, De Backer J, Vos W, Van Holsbeke C, Ferreira F, Quinn DA, Hufkens A, Claes R, De Backer W
Format: Article
Language:English
Published: Dove Medical Press 2016-07-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/pulmonary-vascular-effects-of-pulsed-inhaled-nitric-oxide-in-copd-pati-peer-reviewed-article-COPD
_version_ 1818175382428319744
author Hajian B
De Backer J
Vos W
Van Holsbeke C
Ferreira F
Quinn DA
Hufkens A
Claes R
De Backer W
author_facet Hajian B
De Backer J
Vos W
Van Holsbeke C
Ferreira F
Quinn DA
Hufkens A
Claes R
De Backer W
author_sort Hajian B
collection DOAJ
description Bita Hajian,1 Jan De Backer,2 Wim Vos,2 Cedric Van Holsbeke,2 Francisca Ferreira,2 Deborah A Quinn,3 Annemie Hufkens,1 Rita Claes,1 Wilfried De Backer1 1Department of Respiratory Medicine, University Hospital Antwerp, Edegem, 2FluidDA nv, Antwerp, Belgium; 3Bellerophon Therapeutics, Warren, NJ, USA Introduction: Severe chronic obstructive pulmonary disease (COPD) is often associated with secondary pulmonary hypertension (PH), which worsens prognosis. PH can be lowered by oxygen, but also by inhaled nitric oxide (NO), which has the potential to improve the health status of these patients. NO is an important mediator in vascular reactions in the pulmonary circulation. Oral compounds can act through NO-mediated pathways, but delivering pulsed inhaled NO (iNO) directly to the airways and pulmonary vasculature could equally benefit patients. Therefore, a proof-of-concept study was performed to quantify pulmonary blood vessel caliber changes after iNO administration using computed tomography (CT)-based functional respiratory imaging (FRI). Methods: Six patients with secondary PH due to COPD received “pulsed” iNO in combination with oxygen for 20 minutes via a nasal cannula. Patients underwent a high-resolution CT scan with contrast before and after iNO. Using FRI, changes in volumes of blood vessels and associated lobes were quantified. Oxygen saturation and blood pressure were monitored and patients were asked about their subjective feelings. Results: Pulmonary blood vessel volume increased by 7.06%±5.37% after iNO. A strong correlation (Ω20=0.32, P=0.002) was obtained between ventilation and observed vasodilation, suggesting that using the pulsed system, iNO is directed toward the ventilated zones, which consequently experience more vasodilation. Patients did not develop oxygen desaturation, remained normotensive, and perceived an improvement in their dyspnea sensation. Conclusion: Inhalation of pulsed NO with oxygen causes vasodilation in the pulmonary circulation of COPD patients, mainly in the well-ventilated areas. A high degree of heterogeneity was found in the level of vasodilation. Patients tend to feel better after the treatment. Chronic use trials are warranted. Keywords: pulmonary hypertension, COPD, pulsed inhaled nitric oxide, FRI
first_indexed 2024-12-11T19:59:24Z
format Article
id doaj.art-dedf65b7e6e94983898240c05d9b577f
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-11T19:59:24Z
publishDate 2016-07-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-dedf65b7e6e94983898240c05d9b577f2022-12-22T00:52:34ZengDove Medical PressInternational Journal of COPD1178-20052016-07-012016Issue 11533154127757Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertensionHajian BDe Backer JVos WVan Holsbeke CFerreira FQuinn DAHufkens AClaes RDe Backer WBita Hajian,1 Jan De Backer,2 Wim Vos,2 Cedric Van Holsbeke,2 Francisca Ferreira,2 Deborah A Quinn,3 Annemie Hufkens,1 Rita Claes,1 Wilfried De Backer1 1Department of Respiratory Medicine, University Hospital Antwerp, Edegem, 2FluidDA nv, Antwerp, Belgium; 3Bellerophon Therapeutics, Warren, NJ, USA Introduction: Severe chronic obstructive pulmonary disease (COPD) is often associated with secondary pulmonary hypertension (PH), which worsens prognosis. PH can be lowered by oxygen, but also by inhaled nitric oxide (NO), which has the potential to improve the health status of these patients. NO is an important mediator in vascular reactions in the pulmonary circulation. Oral compounds can act through NO-mediated pathways, but delivering pulsed inhaled NO (iNO) directly to the airways and pulmonary vasculature could equally benefit patients. Therefore, a proof-of-concept study was performed to quantify pulmonary blood vessel caliber changes after iNO administration using computed tomography (CT)-based functional respiratory imaging (FRI). Methods: Six patients with secondary PH due to COPD received “pulsed” iNO in combination with oxygen for 20 minutes via a nasal cannula. Patients underwent a high-resolution CT scan with contrast before and after iNO. Using FRI, changes in volumes of blood vessels and associated lobes were quantified. Oxygen saturation and blood pressure were monitored and patients were asked about their subjective feelings. Results: Pulmonary blood vessel volume increased by 7.06%±5.37% after iNO. A strong correlation (Ω20=0.32, P=0.002) was obtained between ventilation and observed vasodilation, suggesting that using the pulsed system, iNO is directed toward the ventilated zones, which consequently experience more vasodilation. Patients did not develop oxygen desaturation, remained normotensive, and perceived an improvement in their dyspnea sensation. Conclusion: Inhalation of pulsed NO with oxygen causes vasodilation in the pulmonary circulation of COPD patients, mainly in the well-ventilated areas. A high degree of heterogeneity was found in the level of vasodilation. Patients tend to feel better after the treatment. Chronic use trials are warranted. Keywords: pulmonary hypertension, COPD, pulsed inhaled nitric oxide, FRIhttps://www.dovepress.com/pulmonary-vascular-effects-of-pulsed-inhaled-nitric-oxide-in-copd-pati-peer-reviewed-article-COPDCOPDpulmonary hypertensionFRIpulsed inhaled nitricoxide
spellingShingle Hajian B
De Backer J
Vos W
Van Holsbeke C
Ferreira F
Quinn DA
Hufkens A
Claes R
De Backer W
Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
International Journal of COPD
COPD
pulmonary hypertension
FRI
pulsed inhaled nitricoxide
title Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
title_full Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
title_fullStr Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
title_full_unstemmed Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
title_short Pulmonary vascular effects of pulsed inhaled nitric oxide in COPD patients with pulmonary hypertension
title_sort pulmonary vascular effects of pulsed inhaled nitric oxide in copd patients with pulmonary hypertension
topic COPD
pulmonary hypertension
FRI
pulsed inhaled nitricoxide
url https://www.dovepress.com/pulmonary-vascular-effects-of-pulsed-inhaled-nitric-oxide-in-copd-pati-peer-reviewed-article-COPD
work_keys_str_mv AT hajianb pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT debackerj pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT vosw pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT vanholsbekec pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT ferreiraf pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT quinnda pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT hufkensa pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT claesr pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension
AT debackerw pulmonaryvasculareffectsofpulsedinhalednitricoxideincopdpatientswithpulmonaryhypertension